bioRxivCancer Biology
The Repertoire of Mutational Signatures in Human Cancer
L. Alexandrov, J. Kim, N. J. Haradhvala, M. N. Huang, A. W. T. Ng, Y. Wu, A. Boot, K. R. Covington, D. A. Gordenin, E. Bergstrom, S. M. A. Islam, N. Lopez-Bigas, L. J. Klimczak, J. R. McPherson, S. Morganella, R. Sabarinathan, D. A. Wheeler, V. Mustonen, PCAWG Mutational Signatures Working Group, G. Getz, S. G. Rozen, M. R. Stratton
Abstract
Somatic mutations in cancer genomes are caused by multiple mutational processes each of which generates a characteristic mutational signature. Using 84,729,690 somatic mutations from 4,645 whole cancer genome and 19,184 exome sequences encompassing most cancer types we characterised 49 single base substitution, 11 doublet base substitution, four clustered base substitution, and 17 small insertion and deletion mutational signatures. The substantial dataset size compared to previous analyses enabled discovery of new signatures, separation of overlapping signatures and decomposition of signatures into components that may represent associated, but distinct, DNA damage, repair and/or replication mechanisms. Estimation of the contribution of each signature to the mutational catalogues of individual cancer genomes revealed associations with exogenous and endogenous exposures and defective DNA maintenance processes. However, many signatures are of unknown cause. This analysis provides a systematic perspective on the repertoire of mutational processes contributing to the development of human cancer including a comprehensive reference set of mutational signatures in human cancer.
- organism: human
- assay: whole-genome sequencing
- assay: whole-exome sequencing
- research focus: variant calling
- research focus: variant effect prediction
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Compendium of 49 Experimental SBS Signatures for Decoding Human Cancer Mutational Processes
Maria Zhivagui, Jessica N. Au, … Ludmil B. Alexandrov·bioRxiv·Sep 4, 2026
- De Novo Mutational Signature Discovery in Tumor Genomes using SparseSignatures
Avantika Lal, Keli Liu, … Daniele Ramazzotti·PLoS Computational BiologyPeer-reviewed·Jun 28, 2021
- Topography of mutational signatures in human cancer
B. Otlu-Saritas, M. Diaz-Gay, … L. B. Alexandrov·bioRxiv·May 29, 2022
- Signatures of copy number alterations in human cancer
C. D. Steele, A. Abbasi, … N. Pillay·bioRxiv·Apr 30, 2021
- Learning mutational signatures and their multidimensional genomic properties with TensorSignatures
H. Vohringer, A. van Hoeck, … M. Gerstung·bioRxiv·Jun 19, 2020
- CANCERSIGN: a user-friendly and robust tool for identification and classification of mutational signatures and patterns in cancer genomes
Masroor Bayati, Hamid Reza Rabiee, … Hamid Alinejad‐Rokny·Scientific ReportsPeer-reviewed·Jan 28, 2020